Article
Recombinant complement receptor 2 radiolabeled with [99mTc(CO)3]+: a potential new radiopharmaceutical for imaging activated complement.
PloS one - 6 Apr 2011
Badar Adam, DeFreitas Sarah, McDonnell James M, Yahya Norhakim, Thakor David, Razavi Reza, Smith Richard, Sacks Steven, Mullen Gregory E D
Abstract excerpt
We describe the design and synthesis of a new Tc-99m labeled bioconjugate for imaging activated complement, based on Short Consensus Repeats 1 and 2 of Complement Receptor 2 (CR2), the binding domain for C3d. To avoid non specific modification of CR2 and the potential for modifying lysine residues critical to the CR2/C3d contact surface, we engineered a new protein, recombinant CR2 (rCR2), to include the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
